학술논문

The efficacy and safety of ruxolitinib as an add-on therapy to corticosteroids for patients with severe checkpoint inhibitor pneumonitis
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2024, 42 16, 1p. Supplement: S
Subject
Language
English
ISSN
15277755